Table 2. Comparison of recombinant human QPP and purified human DPPII regarding Km and IC50 values observed with different substrates and inhibitors.
pH 5.5 | pH 7.0 | |||
---|---|---|---|---|
DPPII | QPP | DPPII | QPP | |
Km – substrate analysis | ||||
Lys-Ala-pNA | 570±40 | 560±30 | 40±5 | 35±3 |
Ala-Pro-pNA | 40±4 | 30±3 | 9±2 | 7±3 |
Gly-Pro-pNA | 210±30 | 180±30 | 70±6 | 60±5 |
Nle-Nle-pNA | 20±3 | 15±1 | n.d. | n.d. |
IC50 compound 1* | ||||
Lys-Ala-pNA | 1.72±0.06 | 1.19±0.03 | 0.052±0.002 | 0.043±0.002 |
Ala-Pro-pNA | 2.64±0.04 | 2.26±0.04 | 0.063±0.001 | 0.049±0.002 |
IC50 compound 2† | ||||
Lys-Ala-pNA | 0.95±0.04 | 1.10±0.02 | 1.00±0.04 | 0.95±0.01 |
Ala-Pro-pNA | 1.45±0.03 | 1.30±0.02 | 1.05±0.02 | 1.00±0.02 |